Back to search

University of Ioannina

Cannabidiol against stress and Alzheimer's disease brain pathologies

Abstract

dc:description

Modern lifestyle increasingly exposes individuals to persistent psychological stress, an important risk factor contributing to the onset and progression of both stress-related neuropsychiatric disorders (e.g. anxiety and depression), as well as neurological diseases (e.g. Alzheimer´s disease; AD). Emerging evidence suggests that chronic stress is a linking factor between depression and AD, activating common neurobiological mechanisms in both disorders. Previous studies have shown that stress disrupts neuroplasticity, promotes neuroinflammation, and precipitates AD-related mechanisms such as Tau hyperphosphorylation and accumulation. Given the absence of effective disease-modifying therapies for AD and the limited efficacy of current antidepressants in a large proportion of depressed patients, these PhD studies monitor the impact of the phytocannabinoid, cannabidiol (CBD), against Stress and AD brain pathologies. The first part of these PhD studies demonstrates that CBD treatment in chronically stressed Tau transgenic male and female mice counteracts the precipitating effects of chronic stress on Tau pathology and related hippocampal malfunction, leading to attenuation of memory deficits. Using multiscale analytical tools of the brain, such as molecular, cellular, neurostructural, proteomic, and behavioral analyses, we demonstrate for the first time that CBD reduces stress-driven Tau hyperphosphorylation and accumulation as well as neurotoxic aggregation, in parallel to the prevention of neuronal dendritic atrophy and synaptic loss, thereby mitigating downstream memory deficits. Mechanistically, these PhD findings highlight the critical interplay between autophagy and inflammasome activity in mediating the beneficial effects of CBD on stress-exacerbated Tau pathology. The second part of these PhD studies in wild-type mice reveals that, similarly to the widely used antidepressant drug citalopram, CBD mitigates the detrimental impact of chronic stress on hippocampal and prefrontal cortex on plasticity and related behavior. Specifically, CBD blocked stress-induced dysregulation of the endocannabinoid system and also protected against stress-driven synaptic loss and neuronal atrophy, ameliorating anxious behavior and associated memory impairment. Moreover, despite the distinct primary pharmacological targets between CBD and citalopram, hippocampal proteomic analysis uncovers a notable similarity of the effect of both compounds on the hippocampal proteome under chronic stress, suggesting common pathways related to stress neuronal resilience. However, it appears that CBD beneficial effect against stress-evoked damage of neuroplasticity involves the endocannabinoids as CBD, but not citalopram, attenuated the dysregulation of endocannabinoid system triggered by chronic stress, supporting the view that endocannabinoid manipulation may represent an alternative therapeutic target against stress-driven anxious and depressive brain pathology, adding to our current antidepressant drugs portfolio. In contrast to its protective role under pathological conditions, the third part of these PhD studies provides a detailed characterization of molecular mechanisms through which prolonged exposure of the healthy, disease/stress-free brain to CBD causes mild cognitive deficits due to synaptic, but not dendritic, atrophy leading to neuronal malfunction. Based on mice and C. elegans studies, we showed that prolonged CBD exposure induces overactivation of autophagy, disrupts mitochondrial function, leading to synaptic loss, mild memory deficits and increased anxiety levels. This cross-species evidence suggests that CBD action on the brain is highly context-dependent with beneficial effect on stressed brain but harmful impact on the healthy, stress-free brain. Despite that clinical validation of the the beneficial use of CBD in stress-driven depression and anxiety is largely missing, these PhD studies provide novel and multiscale preclinical evidence suggesting the beneficial effects of CBD treatment against the stress-driven damage of neuronal and synaptic integrity while warn about the uncontrolled and prolonged use of CBD by healthy individuals in the our society exhibiting an expanding and largely unregulated CBD market.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Vamvaka-Iakovou, Anastasia
  • Βαμβακά-Ιακώβου, Αναστασία

Subjects

dc:subject × 13

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/60673

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Vamvaka-Iakovou, Anastasia; Βαμβακά-Ιακώβου, Αναστασία. Cannabidiol against stress and Alzheimer's disease brain pathologies. University of Ioannina, 2025. http://hdl.handle.net/10442/hedi/60673